Fresenius Medical Net Worth

Fresenius Medical Net Worth Analysis

Fresenius Medical Target Price Consensus

Fresenius Medical Target Price Projection

Fresenius Medical's current and average target prices are 22.38 and 23.17, respectively. The current price of Fresenius Medical is the price at which Fresenius Medical Care is currently trading. On the other hand, Fresenius Medical's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Fresenius Medical Care and the information provided on this page.

Know Fresenius Medical's Top Institutional Investors

Note, although Fresenius Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Fresenius Medical's market capitalization trends

The company currently falls under 'Large-Cap' category with a total capitalization of 13.22 B.

Project Fresenius Medical's profitablity

The company has Net Profit Margin of 0.03 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.08 %, which entails that for every 100 dollars of revenue, it generated $0.08 of operating income.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Fresenius Medical's management efficiency

Fresenius Medical Care has Return on Asset of 0.0298 % which means that on every $100 spent on assets, it made $0.0298 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0582 %, implying that it generated $0.0582 on every 100 dollars invested. Fresenius Medical's management efficiency ratios could be used to measure how well Fresenius Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.02 in 2025. Return On Capital Employed is likely to drop to 0.05 in 2025. At this time, Fresenius Medical's Debt To Assets are comparatively stable compared to the past year. Fixed Asset Turnover is likely to gain to 5.25 in 2025, whereas Return On Tangible Assets are likely to drop 0.02 in 2025.

Fresenius Medical Corporate Filings

Fresenius Medical time-series forecasting models is one of many Fresenius Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Fresenius Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Fresenius Medical Earnings Estimation Breakdown

The calculation of Fresenius Medical's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Fresenius Medical is estimated to be 0.5147 with the future projection ranging from a low of 0.34 to a high of 0.79. Please be aware that this consensus of annual earnings estimates for Fresenius Medical Care is based on EPS before non-recurring items and includes expenses related to employee stock options.

Fresenius Medical Earnings Projection Consensus

Fresenius Medical Earnings History

Earnings estimate consensus by Fresenius Medical Care analysts from Wall Street is used by the market to judge Fresenius Medical's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Fresenius Medical's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods. Retained Earnings is likely to gain to about 13.2 B in 2025, whereas Earnings Yield is likely to drop 0.05 in 2025. Common Stock Shares Outstanding is likely to gain to about 405.8 M in 2025. Net Income Applicable To Common Shares is likely to gain to about 931.7 M in 2025.

Hype Prediction Low Estimated High 20.59 22.36 24.13 Details

Intrinsic Valuation Low Real High 20.82 22.59 24.36 Details

6 Analysts Consensus Low Target High 21.08 23.17 25.72 Details

Earnings Estimates (0) Low Projected EPS High 0.34 0.51 0.79 Details

Note that many institutional investors and large investment bankers can move markets due to the volume of Fresenius assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Fresenius Medical. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Fresenius Medical's stock price in the short term.

Fresenius Medical Earnings per Share Projection vs Actual

Actual Earning per Share of Fresenius Medical refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Fresenius Medical Care predict the company's earnings will be in the future. The higher the earnings per share of Fresenius Medical, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Fresenius Medical Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Fresenius Medical, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Fresenius Medical should always be considered in relation to other companies to make a more educated investment decision.

Fresenius Quarterly Analyst Estimates and Surprise Metrics

Fresenius Medical Corporate Management

Additional Tools for Fresenius Stock Analysis